108 related articles for article (PubMed ID: 6419386)
1. HLA-A, -B, and -DR antigens in North African patients with nasopharyngeal carcinoma.
Herait P; Tursz T; Guillard MY; Hanna K; Lipinski M; Micheau C; Sancho-Garnier H; Schwaab G; Cachin Y; Degos L
Tissue Antigens; 1983 Nov; 22(5):335-41. PubMed ID: 6419386
[TBL] [Abstract][Full Text] [Related]
2. Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians.
Li X; Ghandri N; Piancatelli D; Adams S; Chen D; Robbins FM; Wang E; Monaco A; Selleri S; Bouaouina N; Stroncek D; Adorno D; Chouchane L; Marincola FM
J Transl Med; 2007 May; 5():22. PubMed ID: 17480220
[TBL] [Abstract][Full Text] [Related]
3. Association between HLA-A/-B antigens and -DRB1 alleles and nasopharyngeal carcinoma in Tunisia.
Mokni-Baizig N; Ayed K; Ayed FB; Ayed S; Sassi F; Ladgham A; Bel Hadj O; El May A
Oncology; 2001; 61(1):55-8. PubMed ID: 11474249
[TBL] [Abstract][Full Text] [Related]
4. New evidence for the existence of HLA-B14 subtypes. Linkage with different DR antigens.
Mueller-Eckhardt G; Mayr WR; Prel L; Mueller-Eckhardt C
Tissue Antigens; 1983 Jan; 21(1):58-61. PubMed ID: 6404003
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibility genes, HLA and diabetic retinopathy in the Algerian population].
Raache R; Hennachi R; Amroune H; Heniche A; Belanteur K; Benyahia A; Ouandjeli KS; Barar A; Houhou D; Mimouni S; Gervais T; Latinne D; Boudiba A; Attal N; Abbadi MC
J Fr Ophtalmol; 2013 Mar; 36(3):247-54. PubMed ID: 22981956
[TBL] [Abstract][Full Text] [Related]
6. Beta 2-microglobulin and HLA-DR expression in relation to the presence of Epstein-Barr virus in nasopharyngeal carcinomas.
Kouvidou C; Rontogianni D; Tzardi M; Datseris G; Panayiotides I; Darivianaki K; Karidi E; Delides G; Kanavaros P
Pathobiology; 1995; 63(6):320-7. PubMed ID: 8738471
[TBL] [Abstract][Full Text] [Related]
7. Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma.
Dardari R; Khyatti M; Jouhadi H; Benider A; Ettayebi H; Kahlain A; Mansouri A; El Gueddari B; Benslimane A
Int J Cancer; 2001 Apr; 92(2):294-7. PubMed ID: 11291059
[TBL] [Abstract][Full Text] [Related]
8. Haplotypes of human leukocyte antigens among patients with nasopharyngeal cancer in Greece.
Daniilidis M; Fountzilas G; Fleva A; Daniilidis J; Tourkantonis A
Oncology; 1997; 54(3):185-92. PubMed ID: 9143397
[TBL] [Abstract][Full Text] [Related]
9. HLA and nasopharyngeal carcinoma in North American Caucasoids.
Moore SB; Pearson GR; Neel HB; Weiland LH
Tissue Antigens; 1983 Jul; 22(1):72-5. PubMed ID: 6577695
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between nasopharyngeal carcinoma and HLA in Sichuan].
Yuan BW
Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):263-6. PubMed ID: 3248481
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies on immunity to EBV-associated antigens in NPC patients in North America, Tunisia, France and Hong Kong.
Levine PH; Wallen WC; Ablashi DV; Granlund DJ; Connelly R
Int J Cancer; 1977 Sep; 20(3):332-8. PubMed ID: 198381
[TBL] [Abstract][Full Text] [Related]
12. HLA and B-lymphocyte alloantigens in Gila River Indians.
Ensroth AF; Mann DL; Johnson AH; Knowler WC; Pettitt DJ; Bennett PH
Tissue Antigens; 1983 Mar; 21(3):198-207. PubMed ID: 6407143
[TBL] [Abstract][Full Text] [Related]
13. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to Epstein-Barr virus capsid antigen and early antigen in nasopharyngeal carcinoma and comparison groups.
Lin TM; Yang CS; Chiou JF; Tu SM; Chen TY; Tu YC; Lin PJ; Kawamura A; Hirayama T
Am J Epidemiol; 1977 Oct; 106(4):336-9. PubMed ID: 199059
[TBL] [Abstract][Full Text] [Related]
15. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
Tiwawech D; Srivatanakul P; Karaluk A; Ishida T
Asian Pac J Cancer Prev; 2003; 4(2):113-8. PubMed ID: 12875623
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR antigens and the antibody response against Epstein-Barr virus.
Cohen JH; Vischer TL; Carquin J; Blanchard F; von Fliedner VE; Jeannet M
Tissue Antigens; 1984 Mar; 23(3):156-62. PubMed ID: 6328695
[TBL] [Abstract][Full Text] [Related]
17. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
Tamada A; Makimoto K; Yamabe H; Imai J; Hinuma Y; Oyagi A; Araki T
Cancer; 1984 Feb; 53(3):430-40. PubMed ID: 6318948
[TBL] [Abstract][Full Text] [Related]
18. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
19. HLA-A, B, DR antigens and insulin-dependent diabetes in Algerians.
Mercier P; Vallo JJ; Vialettes B; Vague P
Tissue Antigens; 1985 Jul; 26(1):20-4. PubMed ID: 3875911
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening.
Chen Y; Zhao W; Lin L; Xiao X; Zhou X; Ming H; Huang T; Liao J; Li Y; Zeng X; Huang G; Ye W; Zhang Z
PLoS One; 2015; 10(7):e0132669. PubMed ID: 26151639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
